Osaic Holdings’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77K | Sell |
233
-3,934
| -94% | -$30K | ﹤0.01% | 6524 |
|
|
2025
Q1 | $33.1K | Buy |
4,167
+3,861
| +1,262% | +$30.7K | ﹤0.01% | 4981 |
|
|
2024
Q4 | $1.66K | Buy |
306
+75
| +32% | +$407 | ﹤0.01% | 6535 |
|
|
2024
Q3 | $1.67K | Sell |
231
-436
| -65% | -$3.15K | ﹤0.01% | 6504 |
|
|
2024
Q2 | $7.24K | Sell |
667
-5,715
| -90% | -$62.1K | ﹤0.01% | 5899 |
|
|
2024
Q1 | $120K | Buy |
6,382
+278
| +5% | +$5.21K | ﹤0.01% | 4112 |
|
|
2023
Q4 | $132K | Sell |
6,104
-6,025
| -50% | -$131K | ﹤0.01% | 4227 |
|
|
2023
Q3 | $250K | Buy |
12,129
+2,289
| +23% | +$47.1K | ﹤0.01% | 3833 |
|
|
2023
Q2 | $463K | Sell |
9,840
-3,520
| -26% | -$165K | ﹤0.01% | 3209 |
|
|
2023
Q1 | $561K | Sell |
13,360
-463
| -3% | -$19.4K | ﹤0.01% | 2999 |
|
|
2022
Q4 | $528K | Buy |
13,823
+150
| +1% | +$5.73K | ﹤0.01% | 2971 |
|
|
2022
Q3 | $536K | Sell |
13,673
-141
| -1% | -$5.53K | ﹤0.01% | 2837 |
|
|
2022
Q2 | $447K | Buy |
13,814
+2,408
| +21% | +$77.9K | ﹤0.01% | 3043 |
|
|
2022
Q1 | $378K | Buy |
11,406
+4,432
| +64% | +$147K | ﹤0.01% | 3488 |
|
|
2021
Q4 | $296K | Buy |
6,974
+4,444
| +176% | +$189K | ﹤0.01% | 3578 |
|
|
2021
Q3 | $111K | Sell |
2,530
-6,681
| -73% | -$293K | ﹤0.01% | 4434 |
|
|
2021
Q2 | $527K | Buy |
9,211
+8,244
| +853% | +$472K | ﹤0.01% | 2982 |
|
|
2021
Q1 | $73K | Sell |
967
-174
| -15% | -$13.1K | ﹤0.01% | 4588 |
|
|
2020
Q4 | $99K | Buy |
1,141
+625
| +121% | +$54.2K | ﹤0.01% | 4042 |
|
|
2020
Q3 | $31K | Sell |
516
-282
| -35% | -$16.9K | ﹤0.01% | 4634 |
|
|
2020
Q2 | $32K | Sell |
798
-95
| -11% | -$3.81K | ﹤0.01% | 4484 |
|
|
2020
Q1 | $25K | Buy |
+893
| New | +$25K | ﹤0.01% | 4448 |
|